Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
Top Cited Papers
- 20 February 2016
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 34 (6), 557-565
- https://doi.org/10.1200/jco.2015.63.0830
Abstract
Purpose There is growing interest to enhance symptom monitoring during routine cancer care using patient-reported outcomes, but evidence of impact on clinical outcomes is limited. Methods We randomly assigned patients receiving routine outpatient chemotherapy for advanced solid tumors at Memorial Sloan Kettering Cancer Center to report 12 common symptoms via tablet computers or to receive usual care consisting of symptom monitoring at the discretion of clinicians. Those with home computers received weekly e-mail prompts to report between visits. Treating physicians received symptom printouts at visits, and nurses received e-mail alerts when participants reported severe or worsening symptoms. The primary outcome was change in health-related quality of life (HRQL) at 6 months compared with baseline, measured by the EuroQol EQ-5D Index. Secondary endpoints included emergency room (ER) visits, hospitalizations, and survival. Results Among 766 patients allocated, HRQL improved among more participants in the intervention group than usual care (34% v 18%) and worsened among fewer (38% v 53%; P < .001). Overall, mean HRQL declined by less in the intervention group than usual care (1.4- v 7.1-point drop; P < .001). Patients receiving intervention were less frequently admitted to the ER (34% v 41%; P = .02) or hospitalized (45% v 49%; P = .08) and remained on chemotherapy longer (mean, 8.2 v 6.3 months; P = .002). Although 75% of the intervention group was alive at 1 year, 69% with usual care survived the year (P = .05), with differences also seen in quality-adjusted survival (mean of 8.7 v. 8.0 months; P = .004). Benefits were greater for participants lacking prior computer experience. Most patients receiving intervention (63%) reported severe symptoms during the study. Nurses frequently initiated clinical actions in response to e-mail alerts. Conclusion Clinical benefits were associated with symptom self-reporting during cancer care.Keywords
This publication has 36 references indexed in Scilit:
- A systematic review of the impact of routine collection of patient reported outcome measures on patients, providers and health organisations in an oncologic settingBMC Health Services Research, 2013
- Do High Symptom Scores Trigger Clinical Actions? An Audit After Implementing Electronic Symptom ScreeningJournal of Oncology Practice, 2012
- Reliability of adverse symptom event reporting by cliniciansQuality of Life Research, 2011
- Enhancing Patient-Provider Communication With the Electronic Self-Report Assessment for Cancer: A Randomized TrialJournal of Clinical Oncology, 2011
- Automated Symptom Alerts Reduce Postoperative Symptom Severity After Cancer Surgery: A Randomized Controlled Clinical TrialJournal of Clinical Oncology, 2011
- Health care providers underestimate symptom intensities of cancer patients: A multicenter European studyHealth and Quality of Life Outcomes, 2010
- Adverse Symptom Event Reporting by Patients vs Clinicians: Relationships With Clinical OutcomesJNCI Journal of the National Cancer Institute, 2009
- Prospects and challenges in using patient-reported outcomes in clinical practiceQuality of Life Research, 2008
- Estimation of minimally important differences in EQ-5D utility and VAS scores in cancerHealth and Quality of Life Outcomes, 2007
- Mapping the EQ-5D Index from the SF-12: US General Population Preferences in a Nationally Representative SampleMedical Decision Making, 2006